MyFinsight
Home
Blog
About
Contact
Download
Download image
US
$965M
(-68.95%↓ Y/Y)
Non Us
$682M
(-68.48%↓ Y/Y)
US
$933M
(-69.98%↓ Y/Y)
Non Us
$423M
(-80.45%↓ Y/Y)
US
$840M
(-72.97%↓ Y/Y)
Non Us
$280M
(-87.06%↓ Y/Y)
Non Us
$411M
(-81.01%↓ Y/Y)
US
$178M
(-94.27%↓ Y/Y)
Medical Essentials
$1,647M
Interventional
$1,357M
Connected Care
$1,120M
Bio Pharma Systems
$590M
Revenues
$4,714M
(-10.58%↓ Y/Y)
Operating income
$93M
(-82.97%↓ Y/Y)
Other income
(expense), net
$86M
(326.32%↑ Y/Y)
Interest income
$9M
(80.00%↑ Y/Y)
Total operating costs
and expenses
$4,620M
(-2.22%↓ Y/Y)
Net (loss) income
from continuing...
-$37M
Income from continuing
operations before income...
$39M
(-89.26%↓ Y/Y)
Interest expense
$149M
(-1.32%↓ Y/Y)
Cost of products sold
$2,560M
(-15.09%↓ Y/Y)
Selling and
administrative expense
$1,213M
(-4.71%↓ Y/Y)
Integration, restructuring
and transaction...
$533M
(492.22%↑ Y/Y)
Research and development
expense
$249M
(-17.55%↓ Y/Y)
Other operating
expense, net
-$66M
(-46.67%↓ Y/Y)
Income tax provision
$76M
(38.18%↑ Y/Y)
Back
Back
Income Statement
header-bd-logo-svg
BECTON DICKINSON & CO (BDX)
header-bd-logo-svg
source: myfinsight.com
BECTON DICKINSON & CO (BDX)